ClearPoint Neuro (CLPT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

ClearPoint Neuro released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 26.56 M and EPS of USD -0.6311

00:00

ClearPoint Neuro released FY2025 Q3 earnings on November 6 After-Market (EST), actual revenue USD 8.861 M (forecast USD 9.6 M), actual EPS USD -0.2072 (forecast USD -0.2)

00:00

Nov6

ClearPoint Neuro Acquires IRRAS Holdings to Enhance Neuro-Critical Care

21:52

Oct14

ClearPoint Neuro Inc. CEO Disposes of Common Stock

20:33

Oct7

ClearPoint Neuro Reports Positive Results from Clinical Study of Prism Neuro Laser Therapy System

20:16

Oct6

ClearPoint Neuro Receives Expanded Regulatory Approval for Its Treatment Delivery Product

20:11

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 8.861 M, Net Income -5.891 M, EPS -0.2072

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 9.215 M, Net Income -5.837 M, EPS -0.2065

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.485 M, Net Income -6.026 M, EPS -0.2173

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More